Skip to main content
Top

Current Breast Cancer Reports

Issue 3/2023

Content (19 Articles)

Partial Breast Radiation

Brian Figueroa, Frank Vicini, Chirag Shah

Management of Local–Regional Recurrence of Breast Cancer

Caressa Hui, Frederick M. Dirbas, Kathleen C. Horst

Radiation Therapy in Patients with Germline Mutations: a Review of the Current Evidence

S. Gillianne DeFoe, Zainab Balogun, Quratulain Sabih, Kristin Lupinacci, Parul Barry

The Future of Lymphedema: Potential Therapeutic Targets for Treatment

Stav Brown, Adana C. Campbell, Kevin Kuonqui, Ananta Sarker, Hyeung Ju Park, Jinyeon Shin, Raghu P. Kataru, Michelle Coriddi, Joseph H. Dayan, Babak J. Mehrara

Practical Approach to Establishing a Lymphedema Screening Program: Tips and Tricks

Derly C. Munoz, Sarah S. Virk, Oluwadamilola T. Oladeru, Pamela Clevenger, Tracy L. Hollen, Mariam W. Hanna, Lisa R. P. Spiguel

Open Access Breast Cancer

Metastatic Triple-Negative Breast Cancer

Xiaojie Zhang, Kay T. Yeung

Breast Cancer Clinical Trials in East Africa

Karishma Sharma, Joseph Abuodha, Manel Haj Mansour, Noureen Karimi, Diana Omare, Yuashita Hussein, Mansoor Saleh

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine